Eric Kallin

Eric Kallin is currently the SVP of Brand Strategy at BGB Group. Previously, Eric held roles such as Director of Brand Strategy at WILDTYPE, Medical Director at Sudler & Hennessey, and Post-Doctoral Scientist at the Center for Genomic Regulation. Eric has extensive experience in areas such as Infectious disease/Vaccines, Oncology, Hematology, and Rare diseases. Eric holds a Ph.D. in Genetics & Molecular Biology from the University of North Carolina at Chapel Hill.